Suppr超能文献

单节段微创经椎间孔腰椎体间融合术后加速康复路径可减少住院时间和阿片类药物消耗。

Enhanced Recovery After Surgery Pathway for Single-Level Minimally Invasive Transforaminal Lumbar Interbody Fusion Decreases Length of Stay and Opioid Consumption.

机构信息

Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois.

Northwestern University, Feinberg School of Medicine, Chicago, Illinois.

出版信息

Neurosurgery. 2021 Feb 16;88(3):648-657. doi: 10.1093/neuros/nyaa493.

Abstract

BACKGROUND

Opioid requirements in the perioperative period in patients undergoing lumbar spine fusion surgery remain problematic. Although minimally invasive surgery (MIS) techniques have been developed, there still remain substantial challenges to reducing length of hospital stay (LOS) because of postoperative opioid requirements.

OBJECTIVE

To study the effect of implementing an enhanced recovery after surgery (ERAS) pathway in patients undergoing a 1-level MIS transforaminal lumbar interbody fusion (MIS TLIF) at our institution.

METHODS

We implemented an ERAS pathway in patients undergoing an elective single-level MIS TLIF for degenerative changes at a single institution. Consecutive patients were enrolled over a 20-mo period and compared with a pre-ERAS group prior to the implementation of the ERAS protocol. The primary outcome was LOS. Secondary outcomes included reduction in morphine milligram equivalent units (MME), pain scores, postoperative urinary retention (POUR), and incidence of postoperative delirium. Patients were compared using the chi-square and Welch's 2-sample t-tests.

RESULTS

A total of 299 patients were evaluated in this study: 87 in the ERAS group and 212 in the pre-ERAS group. In the ERAS group, there was a significant reduction in LOS (3.13 ± 1.53 vs 3.71 ± 2.07 d, P = .019), total admission MME (252.74 ± 317.38 vs 455.91 ± 498.78 MME, P = .001), and the number of patients with POUR (48.3% vs 65.6%, P = .008). There were no differences in pain scores.

CONCLUSION

This is the largest ERAS MIS fusion cohort published to date evaluating a single cohort of patients in a generalizable manner. This ERAS pathway has shown a substantial decrease in LOS and opioid requirements in the immediate perioperative and postoperative period. There is further work to be done to evaluate patients undergoing other complex spine surgical interventions.

摘要

背景

接受腰椎融合手术的患者在围手术期的阿片类药物需求仍然存在问题。尽管已经开发了微创外科(MIS)技术,但由于术后阿片类药物的需求,仍然存在缩短住院时间(LOS)的巨大挑战。

目的

研究在我们机构接受单节段 MIS 经椎间孔腰椎体间融合术(MIS TLIF)的患者实施术后加速康复(ERAS)方案的效果。

方法

我们在一家机构为接受选择性单节段 MIS TLIF 治疗退行性改变的患者实施了 ERAS 方案。连续患者在 20 个月的时间内入组,并与 ERAS 方案实施前的预 ERAS 组进行比较。主要结果是 LOS。次要结果包括吗啡毫克当量单位(MME)减少、疼痛评分、术后尿潴留(POUR)和术后谵妄发生率。使用卡方检验和 Welch 两样本 t 检验对患者进行比较。

结果

本研究共评估了 299 例患者:87 例在 ERAS 组,212 例在预 ERAS 组。在 ERAS 组中,LOS(3.13±1.53 对 3.71±2.07 d,P=0.019)、总入院 MME(252.74±317.38 对 455.91±498.78 MME,P=0.001)和 POUR 患者数量(48.3%对 65.6%,P=0.008)均显著减少。疼痛评分无差异。

结论

这是迄今为止发表的最大的 ERAS MIS 融合队列,以可推广的方式评估了一组单一的患者。该 ERAS 方案在围手术期和术后即刻显著减少了 LOS 和阿片类药物的需求。还需要进一步的工作来评估接受其他复杂脊柱手术干预的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验